Comparative performances of soluble urokinase plasminogen activator receptor and Mid-regional proADM to predict composite death and new heart failure rehospitalisation in acutely breathless patients

29 August 2022 (17:15 - 18:00)
Organised by:
Congress Presentation Part of: Acute heart failure - Biomarkers Biomarkers ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by